S. Phansenee, T. Angkatavanich, K. Rittiluechai, and S. Intharaburan, “Incidence of Cardiotoxicity Associated with The Use of Pegylated Liposomal Doxorubicin in Gynecologic Malignancies”, BSCM, vol. 63, no. 4, pp. 229–233, Oct. 2024.